Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).

Add to Collection

2013 Oct Observational studies C Mathieu, AH Barnett, H Brath, I Conget… - … journal of clinical …, 2013 - Wiley Online Library 44

Full Author : ['Mathieu, C', 'Barnett, A H', 'Brath, H', 'Conget, I', 'de Castro, J J', 'Goke, R', 'Marquez Rodriguez, E', 'Nilsson, P M', 'Pagkalos, E', 'Penfornis, A', 'Schaper, N C', 'Wangnoo, S K', 'Kothny, W', 'Bader, G']
Journal Title : International journal of clinical practice
Chapter : Section3, Section9
Journal Year : 2013
Cited by : 91

AIM: Real-life studies are needed to confirm the clinical relevance of findings from randomised controlled trials (RCTs). This study aimed to assess the effectiveness and tolerability of vildagliptin add-on vs. other oral antihyperglycaemic drugs (OADs) a..... Read More

Keywords : ['reallife worldwide observational study edge', 'vildagliptin vs', 'type diabetes', 'secondline therapy', 'oral agent', 'tolerability', 'effectiveness']
PubMed Link : https://onlinelibrary.wiley.com/doi/abs/10.1111/ijcp.12252
Google Scholar Link : https://scholar.google.com/scholar?cites=10238625827348776166&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).